Rhodiola Rosea Supplement Market Size to Surpass US$ 38 billion by 2033 | Persistence Market Research
March 09, 2023 07:10 ET
|
Persistence Market Research
New York, March 09, 2023 (GLOBE NEWSWIRE) -- The Rhodiola Rosea Supplement Market revenues were estimated at US$ 14 billion in 2022 and are anticipated to grow at a CAGR of 9% from 2023 to 2033,...
Pulmonary Arterial Hypertension Market Worth ($10.88 Billion by 2028) Lead by Asia Pacific Region (6.5% CAGR) – Global Report by The Insight Partners
February 28, 2023 09:03 ET
|
The Insight Partners
New York, Feb. 28, 2023 (GLOBE NEWSWIRE) -- According to The Insight Partners, “Pulmonary Arterial Hypertension Market Size, Share, Growth, Trends and Global Forecast to 2028 - COVID-19 Impact and...
Casana Appoints New CTO To Accelerate Technological Innovation in Remote Patient Monitoring
February 21, 2023 10:00 ET
|
Casana Care, Inc.
ROCHESTER, N.Y., Feb. 21, 2023 (GLOBE NEWSWIRE) -- Casana, the leader in smart toilet heart health monitoring, today announced the appointment of medical device and regulatory veteran, Samir Zahine,...
Outlook on the Atrial Fibrillation Treatment Global Market to 2027 - Rising Prevalence of Cardiovascular Diseases Drives Growth
December 22, 2022 06:38 ET
|
Research and Markets
Dublin, Dec. 22, 2022 (GLOBE NEWSWIRE) -- The "Atrial Fibrillation Treatment Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027" report has been added to ...
$55+ Billion Stroke Management Market Size to Rise at a Stellar CAGR of 7.5% During (2022-2028) - COVID-19 Impact and Global Analysis by The Insight Partners
October 18, 2022 08:40 ET
|
The Insight Partners
New York, Oct. 18, 2022 (GLOBE NEWSWIRE) -- According to The Insight Partners latest market study on "Stroke Management Market Size, Share, Trends, Growth Strategy and Forecast to 2028 – COVID-19...
Hypertension Clinical Trials Pipeline Analysis: 90+ Companies are Working to Improve the Treatment Space | DelveInsight
October 03, 2022 13:00 ET
|
DelveInsight Business Research LLP
New York, USA, Oct. 03, 2022 (GLOBE NEWSWIRE) -- Hypertension Clinical Trials Pipeline Analysis: 90+ Companies are Working to Improve the Treatment Space | DelveInsight As per a statement of World...
Lexaria Bioscience Corp. (NASDAQ: LEXX) Focused on Filling Need for Hypertension Treatment Solution
August 11, 2022 08:30 ET
|
Lexaria Bioscience Corp.
NEW YORK, Aug. 11, 2022 (GLOBE NEWSWIRE) -- NetworkNewsAudio – Lexaria Bioscience Corp. (NASDAQ: LEXX) announces the availability of a broadcast titled, “The Power of Science to Stop a Killer.” To...